Sigyn Therapeutics annual gross profit
2014
2015
2017
2018
2019
2021
2022
2023
2024
Sigyn Therapeutics Gross Profit Growth & History (SIGY)
Sigyn Therapeutics's gross profit was $0 for fiscal 2024.
View full Sigyn Therapeutics company overviewSigyn Therapeutics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | — | — |
| 2019 | 2019-12-31 | $107,657 | $89,021 | +477.68% |
| 2018 | 2018-12-31 | $18,636 | $1,633 | +9.60% |
| 2017 | 2017-12-31 | $17,003 | — | — |
| 2015 | 2015-12-31 | $19,277 | $1,373 | +7.67% |
| 2014 | 2014-12-31 | $17,904 | — | — |
Sigyn Therapeutics quarterly gross profit
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.24
Q1.25
Q2.25
Q3.25
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2024 | 2024-12-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $2,035 | −$22,055 | −91.55% |
| Q2 2020 | 2020-06-30 | $0 | −$47,499 | — |
| Q1 2020 | 2020-03-31 | $493 | −$31,811 | −98.47% |
| Q4 2019 | 2019-12-31 | $3,764 | $82,157 | — |
| Q3 2019 | 2019-09-30 | $24,090 | −$53,701 | −69.03% |
| Q2 2019 | 2019-06-30 | $47,499 | $41,729 | +723.21% |
| Q1 2019 | 2019-03-31 | $32,304 | $18,836 | +139.86% |
| Q4 2018 | 2018-12-31 | −$78,393 | $502,306 | — |
| Q3 2018 | 2018-09-30 | $77,791 | −$79,719 | −50.61% |
| Q2 2018 | 2018-06-30 | $5,770 | −$241,494 | −97.67% |
| Q1 2018 | 2018-03-31 | $13,468 | −$179,460 | −93.02% |
| Q4 2017 | 2017-12-31 | −$580,699 | — | — |
| Q3 2017 | 2017-09-30 | $157,510 | — | — |
| Q2 2017 | 2017-06-30 | $247,264 | — | — |
| Q1 2017 | 2017-03-31 | $192,928 | — | — |
| Q4 2015 | 2015-12-31 | $1 | — | — |
| Q3 2015 | 2015-09-30 | $0 | −$8,775 | — |
| Q2 2015 | 2015-06-30 | $11,509 | — | — |
| Q1 2015 | 2015-03-31 | $7,767 | — | — |
| Q3 2014 | 2014-09-30 | $8,775 | — | — |
Sigyn Therapeutics gross profit trends
Over the last five fiscal years, Sigyn Therapeutics's gross profit decreased from $107,657 to $0, a change of −$107,657. The latest reported quarter, Q3 2025, shows $0.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sigyn Therapeutics source filings ↗